It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Genome-wide association studies have identified numerous variants associated with human complex traits, most of which reside in the non-coding regions, but biological mechanisms remain unclear. However, assigning function to the non-coding elements is still challenging. Here we apply Activity-by-Contact (ABC) model to evaluate enhancer-gene regulation effect by integrating multi-omics data and identified 544,849 connections across 20 cancer types. ABC model outperforms previous approaches in linking regulatory variants to target genes. Furthermore, we identify over 30,000 enhancer-gene connections in colorectal cancer (CRC) tissues. By integrating large-scale population cohorts (23,813 cases and 29,973 controls) and multipronged functional assays, we demonstrate an ABC regulatory variant rs4810856 associated with CRC risk (Odds Ratio = 1.11, 95%CI = 1.05–1.16, P = 4.02 × 10−5) by acting as an allele-specific enhancer to distally facilitate PREX1, CSE1L and STAU1 expression, which synergistically activate p-AKT signaling. Our study provides comprehensive regulation maps and illuminates a single variant regulating multiple genes, providing insights into cancer etiology.
Here, the authors apply the Activity-by-Contact (ABC) model to infer enhancer-gene regulation and the effect of associated variants across multiple cancer types, integrating genetic and multi-omics data. Then, they explore the mechanisms associated with ABC regulatory variants in colorectal cancer.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Wuhan University, Department of Epidemiology and Biostatistics, School of Public Health, Wuhan, China (GRID:grid.49470.3e) (ISNI:0000 0001 2331 6153); Zhongnan Hospital of Wuhan University, Department of Gastrointestinal Oncology, Wuhan, China (GRID:grid.413247.7) (ISNI:0000 0004 1808 0969); Renmin Hospital of Wuhan University, Department of Radiation Oncology, Wuhan, China (GRID:grid.412632.0) (ISNI:0000 0004 1758 2270)
2 Wuhan University, Department of Epidemiology and Biostatistics, School of Public Health, Wuhan, China (GRID:grid.49470.3e) (ISNI:0000 0001 2331 6153)
3 Zhongnan Hospital of Wuhan University, Department of Hepatobiliary and Pancreatic Surgery, Wuhan, China (GRID:grid.413247.7) (ISNI:0000 0004 1808 0969)
4 Wuhan University, Department of Gastrointestinal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China (GRID:grid.49470.3e) (ISNI:0000 0001 2331 6153)
5 Wuhan University, Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China (GRID:grid.49470.3e) (ISNI:0000 0001 2331 6153)
6 Huazhong University of Science and Technology, Department of Urology, Tongji Hospital of Tongji Medical College, Wuhan, China (GRID:grid.33199.31) (ISNI:0000 0004 0368 7223)
7 Renmin Hospital of Wuhan University, Department of Gastrointestinal Surgery, Wuhan, China (GRID:grid.412632.0) (ISNI:0000 0004 1758 2270)
8 Chinese Academy of Medical Sciences and Peking Union Medical College, Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Beijing, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839)
9 Zhongnan Hospital of Wuhan University, Department of Gastrointestinal Oncology, Hubei Cancer Clinical Study Center, Wuhan, China (GRID:grid.413247.7) (ISNI:0000 0004 1808 0969)
10 Wuhan University, Department of Epidemiology and Biostatistics, School of Public Health, Wuhan, China (GRID:grid.49470.3e) (ISNI:0000 0001 2331 6153); Zhongnan Hospital of Wuhan University, Department of Gastrointestinal Oncology, Wuhan, China (GRID:grid.413247.7) (ISNI:0000 0004 1808 0969); Renmin Hospital of Wuhan University, Department of Radiation Oncology, Wuhan, China (GRID:grid.412632.0) (ISNI:0000 0004 1758 2270); Huazhong University of Sciences and Technology, Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Wuhan, China (GRID:grid.33199.31) (ISNI:0000 0004 0368 7223)